BEIJING, May 12 (Xinhua) — The State Administration of supervise and management on food and drug recently issued a notice saying that 11 batches of drugs produced by 7 enterprises were found to be unqualified after random inspection by 6 inspection agencies including Dalian Drug Inspection Institute, the Food and Drug Administration of relevant provinces (autonomous regions and municipalities) has taken control measures such as sealing up and seizing unqualified drugs, requiring enterprises to suspend sales, recall products and make rectification.
According to the notice, unqualified drugs include: diosmin tablets with batch number 150609 produced by Ma Yinglong Pharmaceutical Group Co., Ltd., and compound reserpine triamterene tablets with batch number 160513 produced by Huarun Shuanghe Pharmaceutical Co., Ltd, chengdu Beite Pharmaceutical Co., Ltd. produces batch numbers 150504, and Chifeng Weikang biochemical Pharmaceutical Co., Ltd. produces batch numbers 20150601, 20150602, 20150702 enalapril hydrochlorothiazine chewable tablet and enalapril hydrochlorothiazine dispersible tablets with batch number 20150601, CISEN Pharmaceutical Co., Ltd. produced 1509130912 injection tablets, hainan Huanglong Pharmaceutical Co., Ltd. produces batch numbers of 201512012 and 201602012 for injection, and Gansu Daili Pharmaceutical Co., Ltd. produces batch numbers of 160702 for injection of adenosine cobalt amine. Unqualified items include content determination, dissolution, content uniformity, etc.
The General Administration of Food and Drug Administration requires the Food and Drug Administration of the provinces (autonomous regions and municipalities) where the production enterprise is located to file an investigation on the illegal acts of producing and selling unqualified drugs in accordance with relevant regulations, within three months, the handling results of enterprises or units related to the production and sales of unqualified drugs will be disclosed.
BEIJING, May 12 (Xinhua) — The State Administration of supervise and management on food and drug recently issued a notice saying that 11 batches of drugs produced by 7 enterprises were found to be unqualified after random inspection by 6 inspection agencies including Dalian Drug Inspection Institute, relevant provincial (district, city) Food and Drug Administration has